Copyright
©The Author(s) 2019.
World J Psychiatr. Jan 4, 2019; 9(1): 7-29
Published online Jan 4, 2019. doi: 10.5498/wjp.v9.i1.7
Published online Jan 4, 2019. doi: 10.5498/wjp.v9.i1.7
Details | Any anxiety disorder | Individual anxiety disorders |
Meta-analytic reviews | ||
Kowatch et al[29], 2005. 7 studies of child and adolescent BD (n = 362) | Mean prevalence of any anxiety disorder in BD 27% (range 14%-43%) | |
Vázquez et al[18], 2014. 46 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological and clinical studies - mean 47% (range 24%-88%) | Mean prevalence: PD 22% (1%-40%), PHOBIAS 22% (2%-59%), GAD 20% (7%-42%), PTSD 16% (3%-39%), OCD 13% (5%-48%) |
Amerio et al[30], 2015. 46 studies of comorbid BD and OCD | Pooled prevalence of OCD in BD 17.0%; pooled prevalence of BD in OCD 18.0% | |
Nabavi et al[11], 2015. 52 interview-based studies of outpatients and inpatients | Lifetime prevalence of any anxiety disorder in BD 43% | Lifetime prevalence of: PD 17%, GAD 14%, SAD 13%, PTSD 11%, SP PHOBIA 11%, OCD 11%, AGORA 8% |
Pavlova et al[19], 2015. 40 studies (n = 14914) of community and clinical population | Lifetime prevalence of anxiety disorder in BD 45% | Lifetime prevalence of: GAD 20%, SOC PHOBIA 20%, PD 19%, PTSD 17%; no differences between BP I and BP II |
Tonna et al[31], 2015. 4 studies of adolescent BD- OCD (n = 345) | Pooled prevalence of comorbid OCD in BD among adolescents 23%; greater than adults (14%) | |
Amerio et al[32], 2016. 14 studies of comorbid BD and OCD in BP I and BP II | Pooled prevalence of OCD in BP I 22%; pooled prevalence of BP I in OCD 4% and of BP II in OCD 13.5% | |
Preti et al[33], 2016. 28 studies of comorbid BD and GAD (n = 7894) | Current prevalence 12% and lifetime prevalence 15% of GAD in BD | |
Taskiran et al[34], 2016. 33 studies of child and adolescent BD | Prevalence of any anxiety disorder in BD 44% | Prevalence of: GAD 25%, SEP ANX 22%, OCD 17%, SOC PHOBIA 15%, PD 10% |
Pavlova et al[35], 2017. 10 studies of euthymic BD (n = 2120) | Current prevalence of any anxiety disorder in BD 35% | Current prevalence of: GAD 12%, SAD 10%, SP PHOBIA 10%, OCD 7% |
Yapici Eser et al[20], 2018. 135 studies of comorbid BD and anxiety disorders | Lifetime prevalence 41% and current prevalence 38% of anxiety disorder in BD; lifetime prevalence 38% in BD I and 34% in BD II; current prevalence 31% in BD I and 37% in BD II | Lifetime prevalence: PD 18%, GAD 13%, SAD 13%, OCD 10%; current prevalence: GAD 15%, PD 13%, SAD 12%, OCD 10%; prevalence PD and SAD significantly affected by proportion of BD I patients |
Preti et al[36], 2018. 15 studies of comorbid BD and PD (n = 3391) | Lifetime prevalence: PD 16%; current prevalence: PD 13%; no difference between BP I and BP II | |
Systematic reviews | ||
Strakowski et al[37], 1994. 4 studies of anxiety comorbidity in BD | Mean prevalence: PD 7%-16%, OCD 8%-13% | |
Krishnan[38], 2005. 10 studies of anxiety comorbidity in BD | Mean rate 71% (range 49%-92%) | Mean rates: SOC PHOBIA 47%, PTSD 39%, PD 11%, OCD 10% |
McIntyre et al[8], 2006. 17 studies of anxiety comorbidity in BD | Lifetime rates 16%-79% in 11 studies; usually 30%50%; current prevalence 15%-56% in 8 studies | AGORA lifetime 22%-62%; current 6%-7%; SP PHOBIA lifetime 2%-67%; current 8% SOC PHOBIA lifetime 4%-47%; current 13%-19% GAD lifetime 3%-43%; current 2%-25% PTSD lifetime 7%-37%; current 4%-40% PD lifetime 2%-38%; current 8%-26% OCD lifetime 2%-31%; current 6%-8% |
Tamam[9], 2007. 15 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological and clinical studies 24%-93% | Lifetime prevalence of: SOC PHOBIA 5%-47%, PD 6%-43%, OCD 7%-39%, GAD 3%-43%, PTSD 7%-21% |
Kauer-Sant'Anna et al[15], 2009. 9 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological studies 48%-93% | SP PHOBIA 10%-67%, SOC PHOBIA 8%-47%, PTSD 7%-39%, GAD 3%-42%, PD 5%-33% |
Quarantini et al[39], 2009. PTSD prevalence in BD | Lifetime rates of PTSD in BD 16%-39% | |
Maina et al[16], 2011. 11 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological studies 63%-89%; in clinical samples 11%-79% | PD 4%-39%, OCD 3%-35%, GAD 3%-32%, SOC PHOBIA 2%-31%, PTSD 5%-29% |
Pallanti et al[40], 2011. 10 studies of comorbid BD and OCD | Lifetime prevalence in epidemiological and clinical studies 15%-35% | |
Lala et al[41], 2012. 7 studies of elderly patients | PTSD 5%-11%, PD -current 22%, GAD-current 16%, OTHERS 10%-11% | |
Schaffer et al[10], 2012. 9 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological studies 52%-75% | Lifetime prevalence: OCD 10%-25%, PD 14%-27%, PTSD 16%-39% |
Latalova et al[22], 2013. 12 studies of anxiety comorbidity in BD | Lifetime prevalence in epidemiological studies 75%; in clinical samples 27%-56% | Lifetime prevalence: SOC PHOBIA 47%-52%, SAD 38%, SP PHOBIA 35%, GAD 30%, PTSD 24% (16%-39%), PD 20%, OCD 14% (3%-35%) |
Amerio et al[42], 2014. 64 articles of comorbid BD and OCD | Lifetime prevalence of OCD in BD 11%-21% (mean BP I 15%, BP II 13%); lifetime prevalence of BD in OCD 6%-10% (mean BP I 4%, BP II 9%) | |
Frías et al[43], 2015. 167 studies of child and adolescent BD | Mean prevalence of any anxiety disorder in BD 54% (range 41%-80%) | GAD and SEP ANX rates higher than other disorders; OCD 36%-39%, PD 18%-23%, PTSD 8% |
Sharma[44], 2017. 8 studies of post-partum BD comorbidity | Anecdotal reports of simultaneous onset of comorbid BD-OCD in the postpartum period |
- Citation: Spoorthy MS, Chakrabarti S, Grover S. Comorbidity of bipolar and anxiety disorders: An overview of trends in research. World J Psychiatr 2019; 9(1): 7-29
- URL: https://www.wjgnet.com/2220-3206/full/v9/i1/7.htm
- DOI: https://dx.doi.org/10.5498/wjp.v9.i1.7